Noy Ashkenazy, MD
Retina Specialist · Dallas, TXNPI 1083009260
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,944 of the $2,794 with a category attached, or 69.6%. 8 manufacturers reported payments, led by Dutch Ophthalmic, USA at 28.0% of the total. Reporting peaked in 2022 at $963 and has fallen 83.9% since, to $155 in 2025. That places this record below the midpoint for retina specialist clinicians in TX, where the typical reported total is $2,568.
Across 19 payments — averaging $147.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dutch Ophthalmic, USA$781
- Alcon$759
- Alimera Sciences, Inc.$531
- Genentech USA, Inc.$366
- Eyepoint US, Inc.$220
- Novartis$99
- plus $37 from 2 others
What the payments were for
- Consulting fees$50018%
- Speaking & faculty fees$35013%
- Food & beverage$1,94470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dutch Ophthalmic, USA | 3 | $781 |
| Alcon | 5 | $759 |
| Alimera Sciences, Inc. | 2 | $531 |
| Genentech USA, Inc. | 4 | $366 |
| Eyepoint US, Inc. | 2 | $220 |
| Novartis | 1 | $99 |
| Omeros Corporation | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVA, combined machine$781
- Iluvien$531
- Constellation$188
- DEXYCU$176
- TISSUEBLUE$134
- VABYSMO$122
How this compares
$2,794 in reported general payments places this provider in the 50th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $112,582 |
| IlevroNepafenac | 25 | $9,527 |
| Difluprednate | 28 | $3,137 |
| Prednisolone Acetate | 64 | $2,701 |
| ValacyclovirValacyclovir Hcl | 14 | $1,225 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 46 | $729 |
| Atropine Sulfate | 16 | $692 |
| Brimonidine Tartrate | 35 | $619 |
| Ketorolac Tromethamine | 11 | $454 |
| Latanoprost | 47 | $182 |
| Prednisone | 28 | $161 |
| ErythromycinErythromycin Base | 12 | $143 |
| Timolol Maleate | 19 | $66 |
| MethotrexateMethotrexate Sodium | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisIlevro | $99 | $9,52725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 108 retina specialist providers in Texas.
Other retina specialist in Dallas
- Judy KimDallas$256K
- Gregory KozielecDallas$4K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.